Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Ownership
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Autolus Therapeutics plc (AUTL)
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
08/07/2023
S-8
Form S-8 - Securities to be offered to employees in employee benefit plans:
08/03/2023
6-K
Quarterly results
Docs:
"
6-K
",
"
INDEX TO CONDENSED CONSOLIDATED FINANCIAL
",
"
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
",
"
Autolus Therapeutics Reports Second Quarter 2023 Financial Results and Operational Progress
"
07/21/2023
6-K
Quarterly results
07/10/2023
SC 13G
Paradigm Biocapital Advisors LP reports a 5.8% stake in Autolus Therapeutics plc
07/06/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
"
05/04/2023
6-K
Quarterly results
03/20/2023
SC 13G
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/07/2023
20-F
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
03/01/2023
F-6EF
Form F-6EF - Registration of American Depository Receipt shares, immediately effective:
02/14/2023
SC 13G/A
Nantahala Capital Management, LLC reports a 4.7% stake in Autolus Therapeutics plc
02/14/2023
SC 13G/A
Frazier Life Sciences Public Fund, L.P. reports a 2.2% stake in Autolus Therapeutics plc
02/14/2023
SC 13G
ARMISTICE CAPITAL, LLC reports a 5.9% stake in Autolus Therapeutics, plc
02/14/2023
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/23/2023
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
",
"
Dr. Christian Itin, Chief Executive Officer of Autolus.
"
12/21/2022
6-K
Quarterly results
12/19/2022
SC 13G
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/13/2022
SC 13D/A
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
12/13/2022
SC 13G
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
12/09/2022
6-K
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
"
6-K
",
"
Underwriting Agreement, among the Company and Jefferies LLC, William Blair & Company, L.L.C. and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein
",
"
Opinion of Cooley (UK) LLP, counsel to the Company
",
"
Autolus Announces Pricing of Public Offering
"
12/09/2022
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
12/08/2022
6-K
Quarterly results
12/08/2022
424B5
Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/21/2022
6-K/A
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
11/03/2022
6-K
Quarterly results
10/05/2022
SC 13D/A
PPF Capital Partners Fund B.V. reports a 16.1% stake in AUTOLUS THERAPEUTICS PLC
08/04/2022
6-K
Quarterly results
07/01/2022
6-K
Quarterly results
06/01/2022
6-K
Quarterly results
05/18/2022
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/18/2022
EFFECT
Form EFFECT - Notice of Effectiveness:
05/03/2022
424B3
Form 424B3 - Prospectus [Rule 424(b)(3)]:
04/29/2022
EFFECT
Form EFFECT - Notice of Effectiveness:
Next >>
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy